Hoffmann-La Roche: HIV Infections trials
The registry lists 67 HIV Infections studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 8Phase 2 12Phase 3 17Phase 4 12No phase 18(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) InfectionCompletedNCT02582983Phase 4Results posted
- A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.CompletedNCT00623597Phase 2Results posted
- A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected PatientsTerminatedNCT00488059Phase 4Results posted
- A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment ExperienceCompletedNCT00487188Phase 4Results posted
- A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.CompletedNCT00435929Phase 1Results posted
- BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.CompletedNCT00326963Phase 4Results posted
- GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 InfectionCompletedNCT00105079Phase 3Results posted
- T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and AdolescentsCompletedNCT00022763Phase 2Results posted
- Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT02733419Phase 3
- A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT02569502Phase 4
- An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 InfectionCompletedNCT01902615
- A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected PatientsCompletedNCT01638650Phase 1
- Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV InfectionCompletedNCT01297127
- INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.CompletedNCT00615134Phase 2
- ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.WithdrawnNCT00461266Phase 4
- BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 InfectionCompletedNCT00337701Phase 4
- WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.CompletedNCT00233883Phase 4
- QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT00232908Phase 4
- A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1TerminatedNCT00100984Phase 4
- A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected PatientsCompletedNCT00089492Phase 2
- T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV DrugsCompletedNCT00021554Phase 3
- Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by InjectionStatus unknownNCT00017784Phase 3
- Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal MeningitisCompletedNCT00012467Phase 2
- T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV DrugsCompletedNCT00008528Phase 3
- A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected PatientsCompletedNCT00002448Phase 3
- A Study to Compare Two Anti-HIV Drug CombinationsCompletedNCT00002447Phase 3
- The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV DrugsCompletedNCT00002425Phase 4
- A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney DiseaseCompletedNCT00002397Phase 3
- A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected PatientsCompletedNCT00002383Phase 1
- A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002382Phase 3
- The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and ChildrenCompletedNCT00002380Phase 1
- A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected PatientsCompletedNCT00002378Phase 3
- A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the EyesCompletedNCT00002377Phase 3
- A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected PatientsCompletedNCT00002374Phase 3
- A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002367Phase 3
- A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous TreatmentCompletedNCT00002334Phase 3
- A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take ZidovudineCompletedNCT00002333Phase 2
- A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's SarcomaCompletedNCT00002314Phase 2
- The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSCompletedNCT00002299Not applicable
- A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)CompletedNCT00002279Not applicable
- A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDSCompletedNCT00002273Not applicable
- An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492CompletedNCT00002265Phase 2
- A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDSCompletedNCT00002257Not applicable
- Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.CompletedNCT00002256Not applicable
- A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral GanciclovirCompletedNCT00002251Not applicable
- A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic PurpuraCompletedNCT00002250Phase 1
- A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir TherapyCompletedNCT00002247Not applicable
- A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected AdultsCompletedNCT00002239Phase 2
- Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected PatientsCompletedNCT00002229Phase 4
- A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDSCompletedNCT00002222Not applicable
- A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected PatientsCompletedNCT00002190Phase 2
- A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive PatientsCompletedNCT00002178Phase 3
- A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral DrugsCompletedNCT00002162Phase 2
- Treatment of Psoriasis Using Acitretin in HIV-Positive PatientsCompletedNCT00002143Phase 3
- An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous AccessCompletedNCT00002135Not applicable
- An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical StudiesCompletedNCT00002118Not applicable
- A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV InfectionCompletedNCT00002117Phase 3
- A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and DidanosineCompletedNCT00002096Phase 1
- A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency VirusCompletedNCT00002095Not applicable
- Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV DiseaseCompletedNCT00002081Not applicable
- A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDSCompletedNCT00002034Not applicable
- Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised PatientCompletedNCT00002025Not applicable
- Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus InfectionsCompletedNCT00002024Not applicable
- A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related ComplexCompletedNCT00002005Not applicable
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related ComplexCompletedNCT00002004Phase 1
- A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult VolunteersCompletedNCT00001992Phase 1
- Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddCCompletedNCT00001040Phase 2